We got a mention on Motley Fool yesterday. While it doesn't say anything we don't already know it at least gets our name out there a bit more.
The S&P/ All Ordinaries Index (Index: ^AORD) (ASX: XAO) has added 0.2% on a fairly lacklustre trading day on the ASX, as we head into the close.
Sector performance is mixed, but energy, metals and mining and the gold sector have all been hammered down. That doesn’t mean all stocks have fallen though, and several have posted gains of more than 10% today…
Here’s our view on four stocks surging higher today… ImpediMed Limited (ASX: IPD) has rocketed up more than 28% to around 50 cents. The biotech company announced today that its L-Dex product had received full reimbursement status in the US for all relevant cancer types. ImpediMed says this is a transformational event for the company, with the addressable market growing to 940,000 patients each year, worth in excess of US$350 million.
IPD Price at posting:
51.0¢ Sentiment: Buy Disclosure: Held
